NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

AIDS Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . August 3rd, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in AIDS Vaccine Week | Other Publications

Beth Israel Deaconess Medical Center - Study offers insights into failed HIV-1 vaccine trial

Emory University - Yerkes plays vital role in study challenging prevailing view of AIDS in nonhuman primates

The Wistar Institute - Penn-Wistar team gains insight into HIV vaccine failure

HIV/AIDS - Findings from University of Paris broaden understanding of HIV/AIDS

 HIV/AIDS - Research from L.K. Song and co-authors yields new data on HIV/AIDS

Tuberculosis Therapy - Research on tuberculosis therapy published by scientists at Japan Anti-Tuberculosis Association

Flowers Heritage Foundation - International Health Leaders Join Forces to Boost Routine HIV Screening and Improve Care in Public Health Settings

HIV/AIDS - Shifting Scientific, Health Priorities and Global Economic Downturn Impact Investment in HIV Prevention R&D

HIV/AIDS Co-Infection - Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments

Profectus BioSciences, Inc. - Profectus Biosciences Secures $5M in Series C Venture Funding


Return to Top of Page

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login